These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6105690)

  • 1. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA; Wilbur R
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic trial of tiapride in extrapyramidal syndromes caused by neuroleptics].
    Zarranz JJ; Caso C; Blanco J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):503-8. PubMed ID: 6110319
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
    Diepart E; Cottereau MJ; Deniker P
    Encephale; 1979; 5(4):317-37. PubMed ID: 42528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol-induced tardive dyskinesia in a patient with akathisia.
    Sandyk R
    Ann Neurol; 1985 Sep; 18(3):370. PubMed ID: 4051467
    [No Abstract]   [Full Text] [Related]  

  • 7. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD
    Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE; Povlsen UJ; Meidahl B; Gerlach J
    Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol in the treatment of tardive dyskinesia.
    Perényi A; Farkas A
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract]   [Full Text] [Related]  

  • 14. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 16. A five year follow-up study of tardive dyskinesia.
    Chouinard G; Annable L; Mercier P; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(1):259-63. PubMed ID: 2873614
    [No Abstract]   [Full Text] [Related]  

  • 17. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of tardive dyskinesia with high doses of propranolol].
    Moreira MJ; Karniol IG
    Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299
    [No Abstract]   [Full Text] [Related]  

  • 19. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.